However, presence of PD-1high cells with a phenotype reminiscent of terminally exhausted cells in non-small cell lung cancer also strongly correlated to treatment response with anti-PD-1 [48]. The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.